Preclinical pharmacology modeling of chimeric antigen receptor T therapies

R Kumari, X Ouyang, J Wang, X Xu, M Zheng… - Current Opinion in …, 2021 - Elsevier
Chimeric antigen receptor (CAR) T cells have largely been successful in treating
hematological malignancies in the clinic but have not been as effective in treating solid …
被引用次数：15 相关文章

Preclinical pharmacology modeling of chimeric antigen receptor T therapies

R Kumari, X Ouyang, J Wang, X Xu… - Current opinion in …, 2021 - pubmed.ncbi.nlm.nih.gov
Chimeric antigen receptor (CAR) T cells have largely been successful in treating
hematological malignancies in the clinic but have not been as effective in treating solid …

Preclinical pharmacology modeling of chimeric antigen receptor T therapies.

R Kumari, X Ouyang, J Wang, X Xu… - Current Opinion in …, 2021 - europepmc.org
Chimeric antigen receptor (CAR) T cells have largely been successful in treating
hematological malignancies in the clinic but have not been as effective in treating solid …